The Clinical Study of Dexmedetomidine and Esketamine Combined Infusion Undergoing Modified Radical Mastectomy

NACompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

April 10, 2022

Primary Completion Date

March 20, 2023

Study Completion Date

March 30, 2023

Conditions
Dexmedetomidine, Esketamine, Postoperative Pain and Recovery Quality
Interventions
DRUG

Dexmedetomidine infusion

Patients received dexmedetomidine (0.5 µg/kg over 10 min before the induction of anesthesia), and then dexmedetomidine was infused at a rate of 0.4 μg/kg/h until 20 min before the end of operation

DRUG

Co-administration dexmedetomidine and low-dose esketamine infusion

Patients received a bolus infusion of dexmedetomidine (0.5 µg/kg) and esketamine (0.5 mg/kg)over 10 min before the induction of anesthesia, and then dexmedetomidine were infused at a rate of 0.4 µg/kg/h and 2 µg/kg/min until 20 min before the end of operation, respectively.

DRUG

Co-administration dexmedetomidine and high-dose esketamine infusion

Patients received a bolus infusion of dexmedetomidine (0.5 µg/kg) and esketamine (0.5 mg/kg)over 10 min before the induction of anesthesia, and then dexmedetomidine were infused at a rate of 0.4 µg/kg/h and 4 µg/kg/min until 20 min before the end of operation, respectively.

Trial Locations (1)

246000

Department of Anqing Hospital Anesthesiology, Anqing

All Listed Sponsors
lead

Anqing Municipal Hospital

OTHER